Literature DB >> 22377628

Prospective study of the role of inflammation in renal cancer.

T Qayyum1, P A McArdle, G W Lamb, J J Going, C Orange, M Seywright, P G Horgan, G Oades, M A Aitchison, J Edwards.   

Abstract

BACKGROUND: The local and systemic inflammatory responses provide prognostic information in cancer. The modified Glasgow Prognostic Score (mGPS) provides additional prognostic information than C-reactive protein (CRP) alone when assessing the systemic inflammation in cancer. The aim of this study was to determine the role of local and systemic inflammation in renal cancer.
METHODS: The cohort consisted of 79 patients who had undergone potential curative resection. Systemic inflammation, mGPS, was constructed by measuring preoperative CRP and albumin concentrations and the Klintrup-Makinen score was evaluated histologically for the local inflammatory response. Pathological parameters such as T stage, grade and tumour necrosis were also assessed. The local inflammatory response was assessed by examining all inflammatory cells at the tumour edge on diagnostic haematoxylin and eosin slides.
RESULTS: On univariate analysis, T stage (p < 0.001), grade (p = 0.044) and mGPS (p < 0.001) were significant predictors of cancer-specific survival. On multivariate analysis, mGPS (hazard ratio 8.64, 95% confidence interval 3.5-21.29, p < 0.001) was the only significant independent predictor of cancer-specific survival.
CONCLUSION: A preoperative systemic inflammatory response as measured by the mGPS is an independent predictor of poor cancer-specific survival in renal cancer in patients undergoing potential curative resection.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22377628     DOI: 10.1159/000334971

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  14 in total

1.  SIGIRR Downregulation and Interleukin-1 Signaling Intrinsic to Renal Cell Carcinoma.

Authors:  Maria Elena Mantione; Ilenia Sana; Maria Giovanna Vilia; Michela Riba; Claudio Doglioni; Alessandro Larcher; Umberto Capitanio; Marta Muzio
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

2.  Prognostic value of the Glasgow Prognostic Score in renal cell carcinoma: a meta-analysis.

Authors:  Sung Ryul Shim; Se Joong Kim; Sun Il Kim; Dae Sung Cho
Journal:  World J Urol       Date:  2016-09-24       Impact factor: 4.226

3.  A prospective study of the role of inflammation in bladder cancer.

Authors:  Tahir Qayyum; Peter McArdle; Mustafa Hilmy; James Going; Clare Orange; Morag Seywright; Paul Horgan; Mark Underwood; Joanne Edwards
Journal:  Curr Urol       Date:  2013-02-08

4.  Association between the inflammatory biomarker, C-reactive protein, and the response to radiochemotherapy in patients with esophageal cancer.

Authors:  Harun Badakhshi; David Kaul; Kuai-LE Zhao
Journal:  Mol Clin Oncol       Date:  2016-01-28

5.  Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.

Authors:  Feng Qi; Yunqiu Xu; Yuxiao Zheng; Xiao Li; Yang Gao
Journal:  Ann Transl Med       Date:  2019-10

Review 6.  C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review.

Authors:  Shiva Shrotriya; Declan Walsh; Nabila Bennani-Baiti; Shirley Thomas; Cliona Lorton
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

7.  Neutrophil-lymphocyte ratio in small renal masses.

Authors:  Wassim M Bazzi; Sheila Z Dejbakhsh; Melanie Bernstein; Paul Russo
Journal:  ISRN Urol       Date:  2014-03-12

8.  Genetic control of renal tumorigenesis by the mouse Rtm1 locus.

Authors:  José Ricardo Jensen; Antonella Galvan; Andrea Borrego; Wafa Hanna Koury Cabrera; Orlando Garcia Ribeiro; Nancy Starobinas; Marcelo De Franco; Maurizio Colecchia; Alessia Bertolotti; Tommaso Antonio Dragani; Olga Célia Martinez Ibañez
Journal:  BMC Genomics       Date:  2013-10-22       Impact factor: 3.969

9.  The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.

Authors:  Ross D Dolan; Jason Lim; Stephen T McSorley; Paul G Horgan; Donald C McMillan
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

Review 10.  The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis.

Authors:  Joanna L Sylman; Annachiara Mitrugno; Michelle Atallah; Garth W Tormoen; Joseph J Shatzel; Samuel Tassi Yunga; Todd H Wagner; John T Leppert; Parag Mallick; Owen J T McCarty
Journal:  Front Oncol       Date:  2018-03-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.